Singapore markets close in 3 hours 29 minutes

Straits Times Index
3,322.86
+8.72(+0.26%)
Nikkei
39,086.83
+282.18(+0.73%)
Hang Seng
18,105.33
+77.62(+0.43%)
FTSE 100
8,281.55
+43.83(+0.53%)
Bitcoin USD
61,301.00
-1,261.29(-2.02%)
CMC Crypto 200
1,273.90
-35.82(-2.74%)

MRNA Jul 2024 170.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.5800

0.0000

(0.00%)

As of 03:59PM EDT. Market open.

Simply Wall St.
Insiders At Moderna Sold US$3.3m In Stock, Alluding To Potential Weakness
In the last year, many Moderna, Inc. ( NASDAQ:MRNA ) insiders sold a substantial stake in the company which may have...
Benzinga
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a treatment forpatients suffering from specific type of endometrial cancer. Its pharma peer, BioNTech SE (NASDAQ: BNTX) wasn’t as lucky as also on Monday, the FDA put its experimental cancer drug study on partial clinical hold. Combining Immunotherapy And Chemotherapy Is Emerging As A New Standard In Ca
Zacks
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Moderna (MRNA) concluded the recent trading session at $137.90, signifying a -1.52% move from its prior day's close.